SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Wegovy Cuts BMI 13.5% in Children in Phase 3 Trial

Novo Nordisk said Wegovy cut BMI 13.5% in children aged 6 to under 12 in a Phase 3 trial.

WEGOVY

Related stories